Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Santen Pharmaceutical Co. Ltd. | SZD | Nov 27, 2024 | 10.30 | +1.98 |
Santorius AG Unsponsored ADR (Germany) | SRT4 | Nov 27, 2024 | 33.80 | -2.31 |
Santos Ltd | STS1 | Nov 27, 2024 | 4.05 | 0.00 |
Sanu Gold Corp | L73 | Nov 27, 2024 | 0.01 | -69.39 |
Sanwa Holdings Corp. | XST | Nov 27, 2024 | 28.20 | -1.40 |
SANY INTL | YXS | Nov 27, 2024 | 0.60 | +5.35 |
Sanyo Chemical Industries Ltd. | XSI | Nov 27, 2024 | 24.00 | -0.83 |
SAP SE ADS | SAPA | Nov 27, 2024 | 218.00 | -1.80 |
Sap SE | SAP | Nov 27, 2024 | 220.50 | -1.47 |
Sapiens International Corporation N.V. - | S3P | Nov 27, 2024 | 26.00 | -0.76 |
Sappi Ltd | SPIA | Nov 27, 2024 | 2.52 | -0.79 |
Sappi Ltd | SPI | Nov 27, 2024 | 2.62 | -0.76 |
Sapporo Holdings Ltd. | SBW | Nov 27, 2024 | 53.00 | -0.93 |
Saputo Inc | SB7 | Nov 27, 2024 | 17.44 | -1.75 |
Sarama Resources Ltd | 48S1 | Nov 27, 2024 | 0.01 | +116.67 |
SARATOGA INVES.SED.RP 100 | ZY8 | Nov 27, 2024 | 0.09 | 0.00 |
Sarepta Therapeutics, Inc. | AB3A | Nov 27, 2024 | 123.85 | +13.89 |
Sareum Holdings Plc | RYH0 | Nov 27, 2024 | 0.29 | 0.00 |
Sartorius AG | SRT | Nov 27, 2024 | 175.00 | -0.57 |
Sartorius AG PRF PERPETUAL EUR | SRT3 | Nov 27, 2024 | 219.40 | +1.81 |
Sartorius AG UNsponsored ADR (Germany) | SRT0 | Nov 27, 2024 | 42.00 | 0.00 |
Sartorius Stedim Biotech, Aubagne Ordinary Shares | 56S1 | Nov 27, 2024 | 178.10 | +0.82 |
Sasol Ltd | SAOA | Nov 27, 2024 | 5.00 | -0.99 |
Sasol Ltd. American Depositary Shares | SAO | Nov 27, 2024 | 4.78 | -0.42 |
SASQUATCH RESOURCES CORP. | NQ0 | Nov 27, 2024 | 0.03 | +20.00 |
Sassy Gold | 123 | Nov 27, 2024 | 0.05 | 0.00 |
Satellos Bioscience Inc | 0ITA | Nov 27, 2024 | 0.47 | -2.48 |
SATS | 2S0 | Nov 27, 2024 | 2.06 | +0.98 |
SATS Ltd. | W1J | Nov 27, 2024 | 2.64 | +0.76 |
Saturn Oil & Gas Inc | SMKA | Nov 27, 2024 | 1.44 | -2.30 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.